awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36407379-0C23B222-EE75-4236-B9EC-959C916FEB8F
Q36407379-0C23B222-EE75-4236-B9EC-959C916FEB8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407379-0C23B222-EE75-4236-B9EC-959C916FEB8F
Sorafenib.
P2860
Q36407379-0C23B222-EE75-4236-B9EC-959C916FEB8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407379-0C23B222-EE75-4236-B9EC-959C916FEB8F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2990ba028b5c8d3fbf069d39010b5fa1acad3fd5
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.